Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Over-use of SABA is associated with poor asthma control and greater risk of exacerbations and death. Identifying and addressing the beliefs driving SABA over-reliance is key to reducing over-use. This study aimed to assess the utility, impact and acceptability of the Reliever Reliance Test (RRT), a brief patient self-test behaviour-change tool to identify and address SABA over-reliance. Patients with asthma who completed the RRT in Argentina were invited to an online survey exploring the acceptability of the RRT, and its impact on patients' perceptions of SABA and intention to discuss asthma treatment with a doctor. 93 patients completed the questionnaire. The RRT classified 76/93 (82%) as medium-to-high risk of SABA over-reliance (a mindset where SABA is perceived as the most important aspect of asthma treatment), with 73% of these reporting SABA overuse (3 or more times a week). 75% intended to follow the RRT recommendations to review their asthma treatment with their doctor. The RRT is acceptable to patients and was effective at raising awareness of, identifying and addressing SABA over-reliance and encouraging patients to review their treatment with their doctor.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11538409 | PMC |
| http://dx.doi.org/10.1038/s41533-024-00389-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Trends in inhaler use and associated carbon footprint: a sales data-based study in Europe.
BMJ Open Respir Res
September 2025
Department of Respiratory Medicine, East and North Hertfordshire NHS Trust, Stevenage, UK.
Background: Physicians are being encouraged to favour dry powder inhalers (DPI) over pressurised metered dose inhalers (pMDI) on environmental grounds. The EU is reviewing the F-gas regulation to accelerate emission phase-down targets. Thoughtful use of inhalers can reduce emissions while promoting positive clinical outcomes.
View Article and Find Full Text PDFThe Feasibility and Impact of Implementing Interventions to Reduce Short-Acting β-Agonist Over-Reliance in Asthma: An Expert Opinion.
Adv Ther
August 2025
Department of Pulmonology and Respiratory Medicine, Universitas Indonesia Faculty of Medicine, Persahabatan Hospital, Jakarta, Indonesia.
Asthma poses a significant global health problem. Despite the availability of effective treatments, management practices often fall short of current recommendations. The SABA use IN Asthma (SABINA) programme demonstrated that short-acting β-agonist (SABA) over-reliance significantly contributes to disease burden.
View Article and Find Full Text PDFThe Limitations of Artificial Intelligence in Head and Neck Oncology.
Adv Ther
June 2025
Coordinator of the International Head and Neck Scientific Group, 35100, Padua, Italy.
Artificial intelligence (AI) is revolutionizing head and neck oncology, offering innovations in tumor detection, treatment planning, and patient management. However, its integration into clinical practice is hindered by several limitations. These include clinician mistrust due to a lack of understanding of AI mechanisms, biases in algorithm development, and the potential over-reliance on technology, which may undermine clinical expertise.
View Article and Find Full Text PDFFifteen-minute consultation: Maintenance and reliever therapy for the management of asthma in children and young people.
Arch Dis Child Educ Pract Ed
March 2025
University of Bristol, Bristol, UK
Asthma is the most common chronic disease of childhood. Acute asthma attacks are a frequent reason for emergency presentation in children and young people (CYP), and fatal asthma attacks can occur even in those thought to have mild disease. Asthma treatment in the UK has until recently relied heavily on a strategy of regular 'maintenance' inhaled corticosteroid (ICS) and separate 'reliever' inhalers containing short-acting beta-agonist (SABA) taken as needed to relieve symptoms (most commonly relievers contain salbutamol).
View Article and Find Full Text PDFThe Reliever Reliance Test: evaluating a new tool to address SABA over-reliance.
NPJ Prim Care Respir Med
November 2024
Centre for Behavioural Medicine, University College London, London, UK.
Article Synopsis
- Over-reliance on Short-Acting Beta-Agonists (SABA) leads to poor asthma control and increased risks of exacerbations and death, highlighting the need for intervention.
- The study evaluated the Reliever Reliance Test (RRT), a tool designed to help patients self-assess and change their behavior related to SABA usage.
- Results showed that 82% of participants were at medium-to-high risk for SABA over-reliance, 73% reported SABA overuse, and 75% intended to discuss their treatment with a doctor, indicating that the RRT effectively raised awareness and facilitated discussions about asthma management.